ACHV
Achieve Life Sciences, Inc.
NASDAQ · Healthcare · Biotechnology · CA
$6.61
+3.53%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- 63.82x
- P/S forward
- 15.47x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- -46.40x
- Price / sales
- —
- Price / cash flow
- -14.48x
Enterprise value
- Enterprise value
- $508.6M
- EV / sales
- —
- EV / EBITDA
- -4.51x
- EV / EBIT
- -8.73x
- Market cap
- $681.0M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026